الصفحة الرئيسية>>Signaling Pathways>> Others>>Pamabrom

Pamabrom

رقم الكتالوجGC36845

Pamabron هو مدر للبول شائع بدون وصفة طبية يستخدم للتخفيف من الأعراض المرتبطة بالدورة الشهرية

Products are for research use only. Not for human use. We do not sell to patients.

Pamabrom التركيب الكيميائي

Cas No.: 606-04-2

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
110٫00
متوفر
100mg
100٫00
متوفر
500mg
200٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Pamabron is a common over-the-counter diuretic used for relief of menstrual-associated symptoms. The active diuretic ingredient in pamabrom is 8-bromotheophylline. Pamabrom is available in combination with acetaminophen (paracetamol) for various conditions such as back pain and menstrual relief. The acetaminophen helps reduce menstrual pains and the pamabrom reduces associated bloating.

[1]. Ortiz MI, Rangel-Flores E, Carrillo-AlarcÓn LC, et al. Prevalence and impact of primary dysmenorrhea among Mexican high school students. Int J Gynaecol Obstet. 2009 Dec;107(3):240-3. [2]. Swanson JK, English JC 3rd. Serum sickness-like reaction to Pamabrom. J Drugs Dermatol. 2006 Mar;5(3):284-6. [3]. Di Girolamo G, SÁnchez AJ, De Los Santos AR, et al. Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea• Expert Opin Pharmacother. 2004 Mar;5(3):561-70. [4]. Pamabrom

مراجعات

Review for Pamabrom

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pamabrom

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.